We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
ABIOMED Inc | NASDAQ:ABMD | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 381.02 | 381.02 | 381.02 | 0 | 01:00:00 |
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
OMB APPROVAL
OMB Number: 3235-0287 Estimated average burden hours per response... 0.5 |
|
|
|
1. Name and Address of Reporting Person
*
MINOGUE MICHAEL R |
2. Issuer Name
and
Ticker or Trading Symbol
ABIOMED INC [ ABMD ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__ X __ Director _____ 10% Owner __ X __ Officer (give title below) _____ Other (specify below) Chairman, President, CEO |
C/O ABIOMED, INC.,, 22 CHERRY HILL DRIVE |
3. Date of Earliest Transaction
(MM/DD/YYYY)
|
|
DANVERS, MA 01923 |
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_ X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
||||||||||
1.Title of Security
(Instr. 3) |
2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code
(Instr. 8) |
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) |
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock $.01 par value | 6/21/2018 | M (5) | 105000 (5) | A | $10.03 | 481150 | D | |||
Common Stock $.01 par value | 6/21/2018 | S (6) | 2400 (6) | D | $434.4738 (7) | 478750 | D | |||
Common Stock $.01 par value | 6/21/2018 | S (6) | 7984 (6) | D | $435.6334 (8) | 470766 | D | |||
Common Stock $.01 par value | 6/21/2018 | S (6) | 5481 (6) | D | $436.7592 (9) | 465285 | D | |||
Common Stock $.01 par value | 6/21/2018 | S (6) | 8009 (6) | D | $437.8840 (10) | 457276 | D | |||
Common Stock $.01 par value | 6/21/2018 | S (6) | 30611 (6) | D | $438.6508 (11) | 426655 | D | |||
Common Stock $.01 par value | 6/21/2018 | S (6) | 24497 (6) | D | $439.7387 (12) | 402168 | D | |||
Common Stock $.01 par value | 6/21/2018 | S (6) | 6696 (6) | D | $440.6038 (13) | 395472 | D | |||
Common Stock $.01 par value | 6/21/2018 | S (6) | 3634 (6) | D | $441.7512 (14) | 391838 | D | |||
Common Stock $.01 par value | 6/21/2018 | S (6) | 1293 (6) | D | $442.7477 (15) | 390545 | D | |||
Common Stock $.01 par value | 6/21/2018 | S (6) | 3300 (6) | D | $443.7724 (16) | 387245 | D | |||
Common Stock $.01 par value | 6/21/2018 | S (6) | 4325 (6) | D | $445.1681 (17) | 382920 | D | |||
Common Stock $.01 par value | 6/21/2018 | S (6) | 1605 (6) | D | $445.9237 (18) | 381315 | D | |||
Common Stock $.01 par value | 6/21/2018 | S (6) | 4165 (6) | D | $447.0059 (19) | 377150 | D | |||
Common Stock $.01 par value | 6/21/2018 | S (6) | 1000 (6) | D | $450.06 | 376150 | D | |||
Common Stock $.01 par value | 46654 | I | By Trust - A | |||||||
Common Stock $.01 par value | 73745 | I | By Trust - B | |||||||
Common Stock $.01 par value | 9000 | I | By Trust - C | |||||||
Common Stock $.01 par value | 655 | I | By Trust - D | |||||||
Common Stock $.01 par value | 38560 | I | By Trust - E |
Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) |
|||||||||||||||
1. Title of Derivate Security
(Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any |
4. Trans. Code
(Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
6. Date Exercisable and Expiration Date |
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) |
8. Price of Derivative Security
(Instr. 5) |
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Stock Option (right to buy) (2) | $10.03 | 6/21/2018 | M (5) | 105000 (5) | 6/3/2011 (1) | 6/3/2020 | Common Stock | 105000 | $0 | 0 | D | ||||
Stock Option (Right to Buy) (2) | $22.44 | 5/22/2013 (1) | 5/22/2022 | Common Stock | 0 | 100000 | D | ||||||||
Stock Option (Right to Buy) (2) | $23.15 | 5/14/2014 (1) | 5/14/2024 | Common stock | 0 | 85000 | D | ||||||||
Stock Option (right to buy) (2) | $21.55 | 5/14/2015 (3) | 5/14/2024 | Common Stock | 0 | 85000 | D | ||||||||
Stock Option (right to buy) (2) | $66.25 | 5/13/2016 (3) | 5/13/2025 | Common Stock | 0 | 35000 | D | ||||||||
Stock Option (right to buy) (4) | $99.62 | 5/24/2017 (3) | 5/24/2026 | Common Stock | 0 | 30500 | D | ||||||||
Stock Option (right to buy) (4) | $134.51 | 5/15/2018 (3) | 5/15/2027 | Common Stock | 0 | 33000 | D | ||||||||
Stock Option (right to buy) (4) | $381.97 | 5/16/2019 (3) | 5/16/2028 | Common Stock | 0 | 30000 | D |
Reporting Owners
|
|||||
Reporting Owner Name / Address |
|
||||
Director | 10% Owner | Officer | Other | ||
MINOGUE MICHAEL R
C/O ABIOMED, INC., 22 CHERRY HILL DRIVE DANVERS, MA 01923 |
X |
|
Chairman, President, CEO |
|
Signatures
|
||
/s/ Stephen C. McEvoy (by power of attorney) | 6/25/2018 | |
** Signature of Reporting Person |
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1 Year ABIOMED Chart |
1 Month ABIOMED Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions